US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZYVERSA THERAPEUTICS INC

0.7080

+0.04306.47%

Post-market: 0.6701-0.0379-5.35%18:15 EDT

Volume:105.36K

Turnover:75.57K

Market Cap:1.82M

PE:-0.08

High:0.7400

Open:0.6900

Low:0.6700

Close:0.6650

Loading ...

Overview Company News Filings

Zyversa Therapeutics CEO Issues Shareholder Letter on Parasol Recommendations Expected to Reduce Drug Development Barrier for Rare Kidney Disease, Focal Segmental Glomerulosclerosis (Fsgs)

THOMSON REUTERS

Zyversa Therapeutics: Initiating Small Phase 2a Proof-of-Concept Trial With Var 200 in First Half of 2025 in Patients With Dkd

THOMSON REUTERS

ZyVersa Therapeutics CEO Issues Shareholder Letter on PARASOL Recommendations Expected to Reduce Drug Development Barrier for Rare Kidney Disease, Focal Segmental Glomerulosclerosis (FSGS)

ZyVersa Therapeutics files to sell 4.21M shares of common stock for holders

ZyVersa Therapeutics FY24 EPS $(8.48) Up From $(1,089.70) YoY

Press Release: ZyVersa Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

ZyVersa Therapeutics Highlights Data Published in the Journal of the American Heart Association Demonstrating Inflammasome Inhibition Attenuates Obesity-Associated Cardiomyopathy in Animal Model Study

ZyVersa Therapeutics prices 2.1M shares at 95c in private placement

Zyversa Therapeutics, Inc. Announces Pricing of $2.0 Million Private Placement Priced at the Market

THOMSON REUTERS

ZyVersa Therapeutics highlights data on NLRP3 inflammasome inhibition

BRIEF-Zyversa Therapeutics Files For Prospectus Related To Offer & Resale Of Up To 1.6 Million Shares Of Common Stock By Selling Stockholder - SEC Filing

OTC Markets Hosts Virtual Investor Presentation with Stephen Glover, CEO of ZyVersa Therapeutics, Inc., with Brad Sorensen, Senior Analyst at Zacks SCR

Zacks Small Cap Research

ZyVersa Therapeutics announces publication on ASC Inhibitor IC 100

Life Sciences Investor Forum: Presentations Now Available for Online Viewing

ZyVersa Therapeutics Q3 2024 GAAP EPS $(2.43) Beats $(3.70) Estimate

Zyversa Therapeutics - Qtrly Loss per Share $2.43

THOMSON REUTERS

Life Sciences Investor Forum Agenda Announced for November 14th

S&P 500 Gains 1%; Vimeo Shares Spike Higher

ZyVersa Says Data Show Inflammasome Inhibition May Slow Obesity-Linked Diabetes; Shares Jump

MT Newswires Live

Top Premarket Gainers

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ZVSA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ZVSA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZVSA\",,,,,undefined,":{"symbol":"ZVSA","market":"US","secType":"STK","nameCN":"ZYVERSA THERAPEUTICS INC","latestPrice":0.708,"timestamp":1745438400000,"preClose":0.665,"halted":0,"volume":105363,"hourTrading":{"tag":"盘后","latestPrice":0.6701,"preClose":0.708,"latestTime":"18:15 EDT","volume":27,"amount":18.5286987,"timestamp":1745446556041},"delay":0,"floatShares":2562275,"shares":2568191,"eps":-8.480319,"marketStatus":"Post-Mkt","change":0.043,"latestTime":"04-23 19:19:19 EDT","open":0.69,"high":0.74,"low":0.67,"amount":75565.16774892001,"amplitude":0.105263,"askPrice":0.71,"askSize":10,"bidPrice":0.66,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-8.480319,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745452800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.665,"preHourTrading":{"tag":"盘前","latestPrice":0.696,"preClose":0.665,"latestTime":"09:08 EDT","volume":4691,"amount":3278.5647623,"timestamp":1745413739197},"postHourTrading":{"tag":"盘后","latestPrice":0.6701,"preClose":0.708,"latestTime":"18:15 EDT","volume":27,"amount":18.5286987,"timestamp":1745446556041},"volumeRatio":0.318739},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZVSA\",,,,,undefined,":{"symbol":"ZVSA","floatShares":2562275,"roa":"-26.74%","roe":"-96.10%","lyrEps":-8.480319,"volumeRatio":0.318739,"shares":2568191,"dividePrice":0,"high":0.74,"amplitude":0.105263,"preClose":0.665,"low":0.67,"week52Low":0.5516,"pbRate":"0.21","week52High":6.7,"institutionHeld":0,"latestPrice":0.708,"committee":0.904762,"eps":-8.480319,"divideRate":0,"volume":105363,"delay":0,"ttmEps":-8.480319,"open":0.69,"prevYearClose":1.06,"prevWeekClose":0.6991,"prevMonthClose":0.6286,"prevQuarterClose":0.6286,"fiveDayClose":0.7798,"twentyDayClose":0.718,"sixtyDayClose":1.41},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZVSA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525896963","title":"Zyversa Therapeutics CEO Issues Shareholder Letter on Parasol Recommendations Expected to Reduce Drug Development Barrier for Rare Kidney Disease, Focal Segmental Glomerulosclerosis (Fsgs)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525896963","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525896963?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:57","pubTimestamp":1744113434,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM0TT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZVSA"],"gpt_icon":0},{"id":"2525896957","title":"Zyversa Therapeutics: Initiating Small Phase 2a Proof-of-Concept Trial With Var 200 in First Half of 2025 in Patients With Dkd","url":"https://stock-news.laohu8.com/highlight/detail?id=2525896957","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525896957?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:57","pubTimestamp":1744113434,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM0TT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZVSA"],"gpt_icon":0},{"id":"2525894454","title":"ZyVersa Therapeutics CEO Issues Shareholder Letter on PARASOL Recommendations Expected to Reduce Drug Development Barrier for Rare Kidney Disease, Focal Segmental Glomerulosclerosis (FSGS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525894454","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525894454?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:57","pubTimestamp":1744113420,"startTime":"0","endTime":"0","summary":"WESTON, Fla., April 08, 2025  -- ZyVersa Therapeutics, Inc. , a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory diseases who have unmet medical needs, announces that Stephen C. Glover, Co-Founder, Chairman, Chief Executive Officer, and President, has issued a Shareholder Letter addressing the recent PARASOL recommendations expected to shorten drug development time and approval for rare kidney disease, FSGS. The full text of the letter follows.ZyVersa is developing Cholesterol Efflux MediatorVAR 200 for treatment of chronic kidney diseases, initially focusing on FSGS as the lead. Plans for indication expansion include treatments for Alport Syndrome and Diabetic Kidney Disease. The global drug market for kidney diseases was $18 Billion in 2024, with $30 Billion projected by 2034 .","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zyversa-therapeutics-ceo-issues-shareholder-115700993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZVSA","FSGS","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2525753430","title":"ZyVersa Therapeutics files to sell 4.21M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2525753430","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525753430?lang=en_us&edition=fundamental","pubTime":"2025-04-05 04:50","pubTimestamp":1743799808,"startTime":"0","endTime":"0","summary":"16:48 EDT ZyVersa Therapeutics (ZVSA) files to sell 4.21M shares of common stock for holders Published first on TheFly – the ultimate source for re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-files-to-sell-4-21m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-files-to-sell-4-21m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZVSA","LENZ","BK4139"],"gpt_icon":0},{"id":"2522370306","title":"ZyVersa Therapeutics FY24 EPS $(8.48) Up From $(1,089.70) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2522370306","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522370306?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:18","pubTimestamp":1743081512,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics FY24 EPS $(8.48) Up From $(1,089.70) YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44514150/zyversa-therapeutics-fy24-eps-8-48-up-from-1-089-70-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ZVSA"],"gpt_icon":0},{"id":"2522050543","title":"Press Release: ZyVersa Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2522050543","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522050543?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:15","pubTimestamp":1743081300,"startTime":"0","endTime":"0","summary":"-- Phase 2a proof-of concept clinical trial for Cholesterol Efflux. Mediator VAR 200 in patients with diabetic kidney disease . -- Regulatory path for VAR 200's lead indication, focal segmental. glomerulosclerosis , expected to be shorter based on FDA's. alignment with data supporting proteinuria reduction as a clinical. WESTON, Fla., March 27, 2025  -- ZyVersa Therapeutics, Inc. , a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of renal and inflammatory diseases with high unmet medical needs, reports financial results for full year ending December 31, 2024, and provides business update.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVSA","03160","BK4585","FSGS","BK4099","BK4604","BK4555","TM","BK4139","LENZ","BK4588"],"gpt_icon":0},{"id":"2520670180","title":"ZyVersa Therapeutics Highlights Data Published in the Journal of the American Heart Association Demonstrating Inflammasome Inhibition Attenuates Obesity-Associated Cardiomyopathy in Animal Model Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2520670180","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520670180?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:57","pubTimestamp":1742299020,"startTime":"0","endTime":"0","summary":"In obesity-associated cardiomyopathy , heart muscle is structurally and functionally abnormal, impairing the ability to effectively pump blood. Five-year survival rate is less than 50%, with congestive heart failure and sudden cardiac death predominant causes of death.Data showed that NLRP3 inflammasome inhibition attenuated inflammation, heart muscle enlargement and fibrosis, and improved heart function.Data support the potential of ZyVersa’s Inflammasome ASC Inhibitor IC 100 as an effective treatment option for patients with obesity and its associated cardiovascular comorbidities.WESTON, Fla., March 18, 2025  -- ZyVersa Therapeutics, Inc. , a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, highlights newly published animal model data demonstrating that inflammasome inhibition attenuates obesity-associated cardiomyopathy, which has a 5-year survival rate <50%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zyversa-therapeutics-highlights-data-published-115700084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AFG","ZVSA","LENZ"],"gpt_icon":0},{"id":"2517202152","title":"ZyVersa Therapeutics prices 2.1M shares at 95c in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2517202152","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517202152?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:12","pubTimestamp":1741266744,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics (ZVSA) has entered into a securities purchase agreement with a single healthcare-focused U.S. institutional investor for the p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-prices-2-1m-shares-at-95c-in-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-prices-2-1m-shares-at-95c-in-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZVSA","LENZ","BK4139"],"gpt_icon":0},{"id":"2517154920","title":"Zyversa Therapeutics, Inc. Announces Pricing of $2.0 Million Private Placement Priced at the Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2517154920","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517154920?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:00","pubTimestamp":1741266015,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP10R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZVSA"],"gpt_icon":0},{"id":"2517919437","title":"ZyVersa Therapeutics highlights data on NLRP3 inflammasome inhibition","url":"https://stock-news.laohu8.com/highlight/detail?id=2517919437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517919437?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:55","pubTimestamp":1741179355,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics (ZVSA) highlights newly published data demonstrating cardioprotective effects and improvements in metabolic parameters with in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-highlights-data-on-nlrp3-inflammasome-inhibition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-highlights-data-on-nlrp3-inflammasome-inhibition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","ZVSA"],"gpt_icon":0},{"id":"2493408477","title":"BRIEF-Zyversa Therapeutics Files For Prospectus Related To Offer & Resale Of Up To 1.6 Million Shares Of Common Stock By Selling Stockholder - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2493408477","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493408477?lang=en_us&edition=fundamental","pubTime":"2024-12-21 06:12","pubTimestamp":1734732725,"startTime":"0","endTime":"0","summary":"BRIEF-Zyversa Therapeutics Files For Prospectus Related To Offer & Resale Of Up To 1.6 Million Shares Of Common Stock By Selling Stockholder - SEC FilingZyversa Therapeutics Inc ZVSA.O:ZYVERSA THERAPEUTICS: FILES FOR PROSPECTUS RELATED TO OFFER & RESALE OF UP TO 1.6 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDER - SEC FILINGSource text: [ID:n0001493152-24-051094]Further company coverage: ZVSA.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nFWN3NL1HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVSA","BK4139"],"gpt_icon":0},{"id":"2485448993","title":"OTC Markets Hosts Virtual Investor Presentation with Stephen Glover, CEO of ZyVersa Therapeutics, Inc., with Brad Sorensen, Senior Analyst at Zacks SCR","url":"https://stock-news.laohu8.com/highlight/detail?id=2485448993","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485448993?lang=en_us&edition=fundamental","pubTime":"2024-11-21 20:32","pubTimestamp":1732192320,"startTime":"0","endTime":"0","summary":"Anthony Kraus: Hello, and welcome to Virtual Investor Conferences. My name is Anthony Kraus, and on behalf of OTC markets, as well as our co-host, Zacks Small Cap Research, we're very pleased you have joined us for our next live presentation from ZyVersa Therapeutics, Inc. Their session will be moderated by Brad Sorensen, senior Equity Research Analyst with Zacks Small Cap Research. Please note that you can submit questions for the presenter in the box to the left of the slides. You can also view the company's availability for one-on-one meetings through the Schedule Meetings tab found on the conference platform. At this point, I'm very pleased to welcome Stephen Glover, co-founder, chairman, CEO, and president of ZyVersa Therapeutics, Inc., which trades on the NASDAQ under the symbol ZVSA. Welcome, Stephen.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/otc-markets-hosts-virtual-investor-123200296.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZVSA","SG","BK4139","LENZ","BK4209"],"gpt_icon":0},{"id":"2484415115","title":"ZyVersa Therapeutics announces publication on ASC Inhibitor IC 100","url":"https://stock-news.laohu8.com/highlight/detail?id=2484415115","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484415115?lang=en_us&edition=fundamental","pubTime":"2024-11-20 21:05","pubTimestamp":1732107927,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics (ZVSA) announces newly published data demonstrating that stroke-related cardiovascular injury and dysfunction is induced by AI...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-announces-publication-on-asc-inhibitor-ic-100-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-announces-publication-on-asc-inhibitor-ic-100-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASC","LENZ","ZVSA","BK4139","BK4144"],"gpt_icon":0},{"id":"2483376412","title":"Life Sciences Investor Forum: Presentations Now Available for Online Viewing","url":"https://stock-news.laohu8.com/highlight/detail?id=2483376412","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483376412?lang=en_us&edition=fundamental","pubTime":"2024-11-15 21:35","pubTimestamp":1731677700,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov. 15, 2024  -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Investor Forum, held November 14th are now available for online viewing.The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section.Select companies are accepting 1x1 management meeting requests through November 19th.Virtual Investor Conferences  is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/pFljWkapktZgUPklKmqXAw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/pFljWkapktZgUPklKmqXAw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/life-sciences-investor-forum-presentations-133500021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NRBO","FET","DRMAW","ZVSA","DRMA","MBCOF","CGTX","BK4179"],"gpt_icon":0},{"id":"2483687066","title":"ZyVersa Therapeutics Q3 2024 GAAP EPS $(2.43) Beats $(3.70) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483687066","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483687066?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:14","pubTimestamp":1731590063,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics Q3 2024 GAAP EPS $(2.43) Beats $(3.70) Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41970762/zyversa-therapeutics-q3-2024-gaap-eps-2-43-beats-3-70-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ZVSA"],"gpt_icon":0},{"id":"2483770028","title":"Zyversa Therapeutics - Qtrly Loss per Share $2.43","url":"https://stock-news.laohu8.com/highlight/detail?id=2483770028","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483770028?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:10","pubTimestamp":1731589800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUA301QGL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZVSA"],"gpt_icon":0},{"id":"2482170219","title":"Life Sciences Investor Forum Agenda Announced for November 14th","url":"https://stock-news.laohu8.com/highlight/detail?id=2482170219","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482170219?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:35","pubTimestamp":1731418500,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov. 12, 2024  -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Investor Forum to be held November 14th. This event is co-sponsored by Zacks SCR.Individual investors, institutional investors, advisors, and analysts are invited to attend.It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations, or schedule 1x1 meetings with management.“We’re pleased to feature a group of innovative companies at the upcomingLife Sciences Investor Forum,” said Jason Paltrowitz, Executive Vice President at OTC Markets Group. “Co-sponsored by Zacks Small Cap Research, this virtual conference will provide these companies with the opportunity to share their business strategies and engage more investors.”Virtual Investor Conferences Contact:John M. ViglottiSVP Corporate Services, Investor AccessOTC","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/pFljWkapktZgUPklKmqXAw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/pFljWkapktZgUPklKmqXAw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/life-sciences-investor-forum-agenda-133500963.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4590","ZVSA","DRMAW","BK4588","CGTX","FET","BK4581","DRMA","NRBO","ET","BK4585","BK4561","BK4179","BK4144"],"gpt_icon":0},{"id":"2481631688","title":"S&P 500 Gains 1%; Vimeo Shares Spike Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2481631688","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481631688?lang=en_us&edition=fundamental","pubTime":"2024-11-06 02:36","pubTimestamp":1730831776,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41754396/s-p-500-gains-1-vimeo-shares-spike-higher","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","ESmain","BK4198","QLD","BK4227","BK4585","MNQmain","BK4539","BNOX","UPRO","BK4550","MQ","SSO","SH","SDS","TQQQ","BK4077","BK4551","BK4561","BK4139","BK4504","BK4559","BVS","SPY","NQmain","IVV","QID","BK4534","OEF","PSQ","SQQQ","BK4581",".IXIC","VMEO","BK4007",".SPX","OEX","BK4106","BK4535","VRCA","SPXU","VOO","ZVSA"],"gpt_icon":1},{"id":"2481689499","title":"ZyVersa Says Data Show Inflammasome Inhibition May Slow Obesity-Linked Diabetes; Shares Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2481689499","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481689499?lang=en_us&edition=fundamental","pubTime":"2024-11-05 23:40","pubTimestamp":1730821256,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics  said Tuesday that recently published data show inflammasome inhibition may protect pancreatic islet beta cells and reduce progression from obesity to insulin resistance and type 2 diabetes.ZyVersa's Inflammasome ASC Inhibitor IC 100 aims to reduce obesity-related inflammation by inhibiting inflammasome adaptor protein ASC, the company said.\"This data supports the potential of Inflammasome ASC Inhibitor IC 100, as a key component of obesity care when added to incretins used for weight loss,\" the company said, adding that it plans to initiate phase 1 trials of IC 100 in mid-2025.Shares of ZyVersa rose more than 37% in recent trading.Price: 2.60, Change: +0.77, Percent Change: +42.02","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ZVSA","BK4139"],"gpt_icon":0},{"id":"2481505345","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2481505345","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481505345?lang=en_us&edition=fundamental","pubTime":"2024-11-05 20:46","pubTimestamp":1730810802,"startTime":"0","endTime":"0","summary":"Avalon GloboCare  shares soared 89% pre-bell Tuesday, reversing from Monday's losses.ZyVersa Therapeutics  shares surged 46% after the company said that published data supported the potential of Inflammasome ASC Inhibitor IC 100 as a key component of obesity care.QuinStreet  shares advanced 28% after the company reported late Monday it swung to a fiscal Q1 adjusted profit on higher revenue.Astera Labs  shares rose 24% after the company reported improved Q3 financial results.Price: 3.3800, Change: +0.09, Percent Change: +2.74","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4077","ALAB","ZVSA","BK4205","IE00B19Z4B17.USD","IE00B7SZL793.SGD","IE0031619046.USD","IE00B66KJ199.SGD","QNST","BK4141","ALBT","BK4139","BK4233"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZVSA\",params:#limit:5,,,undefined,":[{"date":"2025-03-27","symbol":"ZVSA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743062400000,"name":null,"time":"Pre-Market","dateTimestamp":1743048000000,"actualEps":null},{"market":"US","date":"2024-11-14","symbol":"ZVSA","fiscalQuarterEnding":"2024/09","expectedEps":-5.8,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":-2.43},{"market":"US","date":"2024-08-09","symbol":"ZVSA","fiscalQuarterEnding":"2024/06","expectedEps":-5.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":-3.31},{"market":"US","date":"2024-05-15","symbol":"ZVSA","fiscalQuarterEnding":"2024/03","expectedEps":-3.7,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"pre","actualEps":-4.53},{"market":"US","date":"2024-04-26","symbol":"ZVSA","defaultRemindTime":1714138200000,"type":"split","dateTimestamp":1714104000000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZVSA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZVSA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ZVSA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ZVSA","date":"2025-04-22","current":-0.190975,"percent":0.50065,"low":-21.281928,"twenty":-7.844246,"median":-0.192694,"eighty":-0.052956,"high":-0.009885,"avg":-2.720217,"sd":3.923732,"marketCap":1797733},"quantilePoints":[{"date":"2022-02-11","current":-7.527467,"twenty":-7.527467,"median":-7.527467,"eighty":-7.527467,"marketCap":95472110},{"date":"2022-02-18","current":-7.542751,"twenty":-7.542751,"median":-7.542751,"eighty":-7.527467,"marketCap":95665962},{"date":"2022-02-25","current":-7.542751,"twenty":-7.542751,"median":-7.542751,"eighty":-7.527467,"marketCap":95665962},{"date":"2022-03-04","current":-7.535109,"twenty":-7.542751,"median":-7.542751,"eighty":-7.535109,"marketCap":95569036},{"date":"2022-03-11","current":-7.550393,"twenty":-7.542751,"median":-7.542751,"eighty":-7.535109,"marketCap":95762888},{"date":"2022-03-18","current":-7.565677,"twenty":-7.550393,"median":-7.542751,"eighty":-7.535109,"marketCap":95956740},{"date":"2022-03-25","current":-7.603888,"twenty":-7.550393,"median":-7.542751,"eighty":-7.542751,"marketCap":96441370},{"date":"2022-04-01","current":-7.603888,"twenty":-7.565677,"median":-7.550393,"eighty":-7.542751,"marketCap":96441370},{"date":"2022-04-08","current":-7.603888,"twenty":-7.603888,"median":-7.550393,"eighty":-7.542751,"marketCap":96441370},{"date":"2022-04-14","current":-7.603888,"twenty":-7.603888,"median":-7.550393,"eighty":-7.542751,"marketCap":96441370},{"date":"2022-04-22","current":-7.852153,"twenty":-7.603888,"median":-7.558035,"eighty":-7.542751,"marketCap":99590164},{"date":"2022-04-29","current":-7.860061,"twenty":-7.603888,"median":-7.565677,"eighty":-7.542751,"marketCap":99690456},{"date":"2022-05-06","current":-7.867968,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99790748},{"date":"2022-05-13","current":-7.836338,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99389580},{"date":"2022-05-20","current":-7.875876,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99891041},{"date":"2022-05-27","current":-7.852153,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99590164},{"date":"2022-06-03","current":-7.875876,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99891041},{"date":"2022-06-10","current":-7.875876,"twenty":-7.867968,"median":-7.603888,"eighty":-7.547336,"marketCap":99891041},{"date":"2022-06-17","current":-7.836338,"twenty":-7.867968,"median":-7.603888,"eighty":-7.550393,"marketCap":99389580},{"date":"2022-06-24","current":-7.875876,"twenty":-7.867968,"median":-7.820523,"eighty":-7.550393,"marketCap":99891041},{"date":"2022-07-01","current":-7.836338,"twenty":-7.867968,"median":-7.836338,"eighty":-7.550393,"marketCap":99389580},{"date":"2022-07-08","current":-7.860061,"twenty":-7.867968,"median":-7.836338,"eighty":-7.550393,"marketCap":99690456},{"date":"2022-07-15","current":-7.875876,"twenty":-7.867968,"median":-7.844246,"eighty":-7.550393,"marketCap":99891041},{"date":"2022-07-22","current":-7.875876,"twenty":-7.874294,"median":-7.844246,"eighty":-7.550393,"marketCap":99891041},{"date":"2022-07-29","current":-7.875876,"twenty":-7.875876,"median":-7.850967,"eighty":-7.550393,"marketCap":99891041},{"date":"2022-08-05","current":-7.891691,"twenty":-7.875876,"median":-7.852153,"eighty":-7.55345,"marketCap":100091625},{"date":"2022-08-12","current":-10.347355,"twenty":-7.875876,"median":-7.852153,"eighty":-7.565677,"marketCap":100292210},{"date":"2022-08-19","current":-10.337007,"twenty":-7.875876,"median":-7.852153,"eighty":-7.565677,"marketCap":100191917},{"date":"2022-08-26","current":-10.337007,"twenty":-7.875876,"median":-7.852153,"eighty":-7.565677,"marketCap":100191917},{"date":"2022-09-02","current":-10.32666,"twenty":-7.875876,"median":-7.852153,"eighty":-7.573319,"marketCap":100091625},{"date":"2022-09-09","current":-10.347355,"twenty":-7.883783,"median":-7.860061,"eighty":-7.603888,"marketCap":100292210},{"date":"2022-09-16","current":-10.316312,"twenty":-7.891691,"median":-7.860061,"eighty":-7.603888,"marketCap":99991333},{"date":"2022-09-23","current":-10.357702,"twenty":-7.907506,"median":-7.860061,"eighty":-7.603888,"marketCap":100392502},{"date":"2022-09-30","current":-10.434782,"twenty":-10.316312,"median":-7.860061,"eighty":-7.603888,"marketCap":100191917},{"date":"2022-10-07","current":-10.445227,"twenty":-10.32666,"median":-7.860061,"eighty":-7.603888,"marketCap":100292210},{"date":"2022-10-14","current":-10.476563,"twenty":-10.32666,"median":-7.867968,"eighty":-7.603888,"marketCap":100593086},{"date":"2022-10-21","current":-10.497453,"twenty":-10.337007,"median":-7.867968,"eighty":-7.603888,"marketCap":100793671},{"date":"2022-10-28","current":-10.476563,"twenty":-10.337007,"median":-7.875876,"eighty":-7.603888,"marketCap":100593086},{"date":"2022-11-04","current":-10.507899,"twenty":-10.347355,"median":-7.875876,"eighty":-7.603888,"marketCap":100893963},{"date":"2022-11-11","current":-10.539234,"twenty":-10.357702,"median":-7.875876,"eighty":-7.603888,"marketCap":101194839},{"date":"2022-11-18","current":-10.586238,"twenty":-10.378397,"median":-7.875876,"eighty":-7.603888,"marketCap":101646154},{"date":"2022-11-25","current":-10.643686,"twenty":-10.434782,"median":-7.875876,"eighty":-7.603888,"marketCap":102197761},{"date":"2022-12-02","current":-10.654132,"twenty":-10.466118,"median":-7.875876,"eighty":-7.603888,"marketCap":102298054},{"date":"2022-12-09","current":-10.121425,"twenty":-10.466118,"median":-7.875876,"eighty":-7.603888,"marketCap":97183151},{"date":"2022-12-16","current":-2.562,"twenty":-10.466118,"median":-7.875876,"eighty":-7.603888,"marketCap":29243788},{"date":"2022-12-23","current":-1.710652,"twenty":-10.466118,"median":-7.875876,"eighty":-7.603888,"marketCap":19526132},{"date":"2022-12-30","current":-1.249174,"twenty":-10.453583,"median":-7.875876,"eighty":-7.603888,"marketCap":14258617},{"date":"2023-01-06","current":-1.281,"twenty":-10.441049,"median":-7.875876,"eighty":-7.580961,"marketCap":14621894},{"date":"2023-01-13","current":-2.752956,"twenty":-10.434782,"median":-7.875876,"eighty":-7.556507,"marketCap":31423450},{"date":"2023-01-20","current":-1.718609,"twenty":-10.434782,"median":-7.875876,"eighty":-7.550393,"marketCap":19616951},{"date":"2023-01-27","current":-1.670869,"twenty":-10.434782,"median":-7.875876,"eighty":-7.550393,"marketCap":19072036},{"date":"2023-02-03","current":-1.933435,"twenty":-10.434782,"median":-7.867968,"eighty":-7.542751,"marketCap":22069070},{"date":"2023-02-10","current":-1.607217,"twenty":-10.424337,"median":-7.867968,"eighty":-7.542751,"marketCap":18345482},{"date":"2023-02-17","current":-1.869782,"twenty":-10.381724,"median":-7.860061,"eighty":-7.536637,"marketCap":21342516},{"date":"2023-02-24","current":-1.702696,"twenty":-10.378397,"median":-7.860061,"eighty":-7.527467,"marketCap":19435313},{"date":"2023-03-03","current":-1.654956,"twenty":-10.357702,"median":-7.860061,"eighty":-4.265844,"marketCap":18890397},{"date":"2023-03-10","current":-1.670869,"twenty":-10.357702,"median":-7.860061,"eighty":-2.418782,"marketCap":19072036},{"date":"2023-03-17","current":-1.400348,"twenty":-10.357702,"median":-7.860061,"eighty":-2.060739,"marketCap":15984182},{"date":"2023-03-24","current":-1.734522,"twenty":-10.357702,"median":-7.852153,"eighty":-1.958179,"marketCap":19798589},{"date":"2023-03-31","current":-1.535609,"twenty":-10.357702,"median":-7.852153,"eighty":-1.869782,"marketCap":17528109},{"date":"2023-04-06","current":-1.400348,"twenty":-10.351494,"median":-7.852153,"eighty":-1.858643,"marketCap":15984182},{"date":"2023-04-14","current":-1.154538,"twenty":-10.347355,"median":-7.852153,"eighty":-1.802948,"marketCap":16305101},{"date":"2023-04-21","current":-1.141492,"twenty":-10.347355,"median":-7.852153,"eighty":-1.755336,"marketCap":16120863},{"date":"2023-04-28","current":-0.327576,"twenty":-10.347355,"median":-7.850967,"eighty":-1.734569,"marketCap":4626227},{"date":"2023-05-05","current":-0.37167,"twenty":-10.347355,"median":-7.844246,"eighty":-1.722141,"marketCap":5248953},{"date":"2023-05-12","current":-0.323359,"twenty":-10.347355,"median":-7.844246,"eighty":-1.702696,"marketCap":4566681},{"date":"2023-05-19","current":-0.244626,"twenty":-10.341146,"median":-7.836338,"eighty":-1.670869,"marketCap":3404726},{"date":"2023-05-26","current":-0.271366,"twenty":-10.337007,"median":-7.836338,"eighty":-1.65973,"marketCap":3776888},{"date":"2023-06-02","current":-0.595797,"twenty":-10.337007,"median":-7.82843,"eighty":-1.607217,"marketCap":8292357},{"date":"2023-06-09","current":-0.579813,"twenty":-10.337007,"median":-7.820523,"eighty":-1.591304,"marketCap":8069879},{"date":"2023-06-16","current":-0.561146,"twenty":-10.337007,"median":-7.603888,"eighty":-1.559478,"marketCap":7810081},{"date":"2023-06-23","current":-0.440415,"twenty":-10.337007,"median":-7.603888,"eighty":-1.529243,"marketCap":6129730},{"date":"2023-06-30","current":-0.430212,"twenty":-10.337007,"median":-7.603888,"eighty":-1.457635,"marketCap":5987729},{"date":"2023-07-07","current":-0.408107,"twenty":-10.332868,"median":-7.603888,"eighty":-1.400348,"marketCap":5680059},{"date":"2023-07-14","current":-0.425111,"twenty":-10.32666,"median":-7.603888,"eighty":-1.296913,"marketCap":5916728},{"date":"2023-07-21","current":-0.368996,"twenty":-10.32666,"median":-7.603888,"eighty":-1.261904,"marketCap":5135720},{"date":"2023-07-28","current":-0.313371,"twenty":-10.32666,"median":-7.603888,"eighty":-1.163669,"marketCap":4361521},{"date":"2023-08-04","current":-0.309309,"twenty":-10.32666,"median":-7.565677,"eighty":-1.141492,"marketCap":4304983},{"date":"2023-08-11","current":-0.307181,"twenty":-10.32666,"median":-7.558035,"eighty":-1.11801,"marketCap":4275368},{"date":"2023-08-18","current":-0.303699,"twenty":-10.32666,"median":-7.550393,"eighty":-1.058,"marketCap":4226907},{"date":"2023-08-25","current":-0.051589,"twenty":-10.32666,"median":-7.550393,"eighty":-0.57554,"marketCap":4665022},{"date":"2023-09-01","current":-0.048582,"twenty":-10.32666,"median":-7.550393,"eighty":-0.562665,"marketCap":4393153},{"date":"2023-09-08","current":-0.041989,"twenty":-10.32666,"median":-7.542751,"eighty":-0.558863,"marketCap":3796895},{"date":"2023-09-15","current":-0.060169,"twenty":-10.320451,"median":-7.542751,"eighty":-0.517114,"marketCap":5440931},{"date":"2023-09-22","current":-0.052281,"twenty":-10.316312,"median":-7.542751,"eighty":-0.441231,"marketCap":4727605},{"date":"2023-09-29","current":-0.060153,"twenty":-10.303896,"median":-7.542751,"eighty":-0.431743,"marketCap":5439425},{"date":"2023-10-06","current":-0.062896,"twenty":-10.295618,"median":-7.542751,"eighty":-0.424227,"marketCap":5687462},{"date":"2023-10-13","current":-0.06304,"twenty":-10.253773,"median":-7.535109,"eighty":-0.407903,"marketCap":5700517},{"date":"2023-10-20","current":-0.061644,"twenty":-10.163206,"median":-7.527467,"eighty":-0.38615,"marketCap":5574322},{"date":"2023-10-27","current":-0.055581,"twenty":-10.142315,"median":-7.523646,"eighty":-0.376992,"marketCap":5026028},{"date":"2023-11-03","current":-0.046534,"twenty":-8.35029,"median":-4.265844,"eighty":-0.362186,"marketCap":4207939},{"date":"2023-11-10","current":-0.035803,"twenty":-7.907506,"median":-2.657478,"eighty":-0.333478,"marketCap":3237545},{"date":"2023-11-17","current":-0.036701,"twenty":-7.907506,"median":-2.17213,"eighty":-0.328592,"marketCap":3289764},{"date":"2023-11-24","current":-0.040004,"twenty":-7.907506,"median":-2.068696,"eighty":-0.324245,"marketCap":3585846},{"date":"2023-12-01","current":-0.031557,"twenty":-7.898017,"median":-2.024935,"eighty":-0.316333,"marketCap":2828641},{"date":"2023-12-08","current":-0.015952,"twenty":-7.891691,"median":-1.958179,"eighty":-0.309502,"marketCap":1429861},{"date":"2023-12-15","current":-0.01023,"twenty":-7.891691,"median":-1.901609,"eighty":-0.307413,"marketCap":916976},{"date":"2023-12-22","current":-0.048692,"twenty":-7.886946,"median":-1.861826,"eighty":-0.30211,"marketCap":4364571},{"date":"2023-12-29","current":-0.055512,"twenty":-7.883783,"median":-1.857848,"eighty":-0.290163,"marketCap":4975946},{"date":"2024-01-05","current":-0.052962,"twenty":-7.883783,"median":-1.853869,"eighty":-0.285597,"marketCap":4747336},{"date":"2024-01-12","current":-0.047393,"twenty":-7.883783,"median":-1.802152,"eighty":-0.251536,"marketCap":4248168},{"date":"2024-01-19","current":-0.034922,"twenty":-7.879039,"median":-1.770326,"eighty":-0.072424,"marketCap":3130284},{"date":"2024-01-26","current":-0.038707,"twenty":-7.875876,"median":-1.750753,"eighty":-0.065177,"marketCap":3469529},{"date":"2024-02-02","current":-0.034243,"twenty":-7.875876,"median":-1.742518,"eighty":-0.062982,"marketCap":3069461},{"date":"2024-02-09","current":-0.03412,"twenty":-7.875876,"median":-1.734522,"eighty":-0.061606,"marketCap":3058450},{"date":"2024-02-16","current":-0.03374,"twenty":-7.875876,"median":-1.721553,"eighty":-0.060163,"marketCap":3024368},{"date":"2024-02-23","current":-0.036285,"twenty":-7.875876,"median":-1.710652,"eighty":-0.059241,"marketCap":3252454},{"date":"2024-03-01","current":-0.064345,"twenty":-7.875876,"median":-1.702696,"eighty":-0.0586,"marketCap":5767693},{"date":"2024-03-08","current":-0.080782,"twenty":-7.875876,"median":-1.674847,"eighty":-0.059241,"marketCap":7241014},{"date":"2024-03-15","current":-0.06769,"twenty":-7.875876,"median":-1.670869,"eighty":-0.060042,"marketCap":6067487},{"date":"2024-03-22","current":-0.069477,"twenty":-7.875876,"median":-1.658934,"eighty":-0.060153,"marketCap":6227737},{"date":"2024-03-28","current":-0.060072,"twenty":-7.875876,"median":-1.619152,"eighty":-0.060088,"marketCap":5904958},{"date":"2024-04-05","current":-0.057206,"twenty":-7.875876,"median":-1.599261,"eighty":-0.058057,"marketCap":5623190},{"date":"2024-04-12","current":-0.057947,"twenty":-7.875876,"median":-1.591304,"eighty":-0.057773,"marketCap":5696100},{"date":"2024-04-19","current":-0.048367,"twenty":-7.875876,"median":-1.559478,"eighty":-0.05663,"marketCap":4754345},{"date":"2024-04-26","current":-0.046937,"twenty":-7.875876,"median":-1.533619,"eighty":-0.055531,"marketCap":4613841},{"date":"2024-05-03","current":-0.044349,"twenty":-7.875876,"median":-1.495826,"eighty":-0.054896,"marketCap":4359415},{"date":"2024-05-10","current":-0.040795,"twenty":-7.875876,"median":-1.424376,"eighty":-0.05319,"marketCap":4010054},{"date":"2024-05-17","current":-0.037826,"twenty":-7.875876,"median":-1.400348,"eighty":-0.051973,"marketCap":3691072},{"date":"2024-05-24","current":-0.03339,"twenty":-7.875876,"median":-1.308848,"eighty":-0.051476,"marketCap":3258245},{"date":"2024-05-31","current":-0.031755,"twenty":-7.875876,"median":-1.292934,"eighty":-0.050906,"marketCap":3098678},{"date":"2024-06-07","current":-0.03697,"twenty":-7.875876,"median":-1.281,"eighty":-0.049989,"marketCap":3607530},{"date":"2024-06-14","current":-0.041742,"twenty":-7.875876,"median":-1.23334,"eighty":-0.049025,"marketCap":4073207},{"date":"2024-06-21","current":-0.041325,"twenty":-7.875876,"median":-1.167583,"eighty":-0.048602,"marketCap":4032547},{"date":"2024-06-28","current":-0.030973,"twenty":-7.875876,"median":-1.16106,"eighty":-0.048367,"marketCap":3022323},{"date":"2024-07-05","current":-0.030887,"twenty":-7.875876,"median":-1.141492,"eighty":-0.047431,"marketCap":3013974},{"date":"2024-07-12","current":-0.043208,"twenty":-7.875876,"median":-1.134969,"eighty":-0.046921,"marketCap":4216224},{"date":"2024-07-15","current":-0.041924,"twenty":-7.875876,"median":-1.128446,"eighty":-0.046855,"marketCap":4090990},{"date":"2024-08-02","current":-0.029261,"twenty":-7.875876,"median":-1.128446,"eighty":-0.046715,"marketCap":2855344},{"date":"2024-08-09","current":-0.025753,"twenty":-7.875876,"median":-1.108878,"eighty":-0.04506,"marketCap":2513036},{"date":"2024-08-16","current":-0.142372,"twenty":-7.875876,"median":-1.069741,"eighty":-0.045348,"marketCap":3108171},{"date":"2024-08-23","current":-0.142372,"twenty":-7.874294,"median":-0.579813,"eighty":-0.045816,"marketCap":3108171},{"date":"2024-08-30","current":-0.130115,"twenty":-7.867968,"median":-0.574291,"eighty":-0.046563,"marketCap":2840580},{"date":"2024-09-06","current":-0.132,"twenty":-7.867968,"median":-0.567606,"eighty":-0.04668,"marketCap":2881748},{"date":"2024-09-13","current":-0.105129,"twenty":-7.867968,"median":-0.561146,"eighty":-0.046855,"marketCap":2295107},{"date":"2024-09-20","current":-0.107014,"twenty":-7.867968,"median":-0.545154,"eighty":-0.046937,"marketCap":2336274},{"date":"2024-09-27","current":-0.108429,"twenty":-7.867968,"median":-0.494999,"eighty":-0.04713,"marketCap":2367150},{"date":"2024-10-04","current":-0.111201,"twenty":-7.860061,"median":-0.442115,"eighty":-0.047393,"marketCap":2427682},{"date":"2024-10-11","current":-0.11563,"twenty":-7.860061,"median":-0.437694,"eighty":-0.04744,"marketCap":2524360},{"date":"2024-10-18","current":-0.111201,"twenty":-7.860061,"median":-0.431488,"eighty":-0.047955,"marketCap":2427682},{"date":"2024-10-25","current":-0.101853,"twenty":-7.860061,"median":-0.426981,"eighty":-0.048002,"marketCap":2223585},{"date":"2024-10-31","current":-0.098959,"twenty":-7.860061,"median":-0.4229,"eighty":-0.048294,"marketCap":2160422},{"date":"2024-11-08","current":-0.07479,"twenty":-7.860061,"median":-0.412358,"eighty":-0.048539,"marketCap":1632777},{"date":"2024-11-15","current":-0.055601,"twenty":-7.860061,"median":-0.407596,"eighty":-0.048609,"marketCap":1213841},{"date":"2024-11-22","current":-0.057411,"twenty":-7.860061,"median":-0.384846,"eighty":-0.048677,"marketCap":1224583},{"date":"2024-11-29","current":-0.118021,"twenty":-7.860061,"median":-0.371269,"eighty":-0.048708,"marketCap":2517426},{"date":"2024-12-06","current":-0.113252,"twenty":-7.860061,"median":-0.366321,"eighty":-0.048948,"marketCap":2415688},{"date":"2024-12-13","current":-0.118692,"twenty":-7.860061,"median":-0.339908,"eighty":-0.049263,"marketCap":2531726},{"date":"2024-12-20","current":-0.136276,"twenty":-7.860061,"median":-0.332663,"eighty":-0.049654,"marketCap":2906796},{"date":"2024-12-27","current":-0.135177,"twenty":-7.856898,"median":-0.328846,"eighty":-0.049901,"marketCap":2883354},{"date":"2025-01-03","current":-0.119791,"twenty":-7.852153,"median":-0.327576,"eighty":-0.050145,"marketCap":2555168},{"date":"2025-01-10","current":-0.129682,"twenty":-7.852153,"median":-0.324836,"eighty":-0.050769,"marketCap":2766145},{"date":"2025-01-17","current":-0.148365,"twenty":-7.852153,"median":-0.320528,"eighty":-0.050891,"marketCap":3164657},{"date":"2025-01-24","current":-0.165949,"twenty":-7.852153,"median":-0.316323,"eighty":-0.050891,"marketCap":3539728},{"date":"2025-01-31","current":-0.151662,"twenty":-7.852153,"median":-0.310469,"eighty":-0.050903,"marketCap":3234983},{"date":"2025-02-07","current":-0.135726,"twenty":-7.852153,"median":-0.309502,"eighty":-0.051217,"marketCap":2895075},{"date":"2025-02-14","current":-0.14287,"twenty":-7.852153,"median":-0.307568,"eighty":-0.05144,"marketCap":3047448},{"date":"2025-02-21","current":-0.134078,"twenty":-7.852153,"median":-0.304393,"eighty":-0.051476,"marketCap":2859913},{"date":"2025-02-28","current":-0.128583,"twenty":-7.852153,"median":-0.301891,"eighty":-0.051476,"marketCap":2742703},{"date":"2025-03-07","current":-0.097811,"twenty":-7.852153,"median":-0.288309,"eighty":-0.051544,"marketCap":2086329},{"date":"2025-03-14","current":-0.08803,"twenty":-7.852153,"median":-0.285224,"eighty":-0.051753,"marketCap":1877696},{"date":"2025-03-21","current":-0.07704,"twenty":-7.852153,"median":-0.271366,"eighty":-0.051882,"marketCap":1643277},{"date":"2025-03-28","current":-0.076919,"twenty":-7.851441,"median":-0.246413,"eighty":-0.052127,"marketCap":1640699},{"date":"2025-04-04","current":-0.166148,"twenty":-7.850967,"median":-0.166148,"eighty":-0.052638,"marketCap":1564028},{"date":"2025-04-11","current":-0.210427,"twenty":-7.846934,"median":-0.172378,"eighty":-0.052911,"marketCap":1980845},{"date":"2025-04-17","current":-0.194413,"twenty":-7.844246,"median":-0.202243,"eighty":-0.052945,"marketCap":1830092},{"date":"2025-04-22","current":-0.190975,"twenty":-7.844246,"median":-0.192694,"eighty":-0.052956,"marketCap":1797733}],"updateTime":1745410593658}}}